来源：生命科学前沿
在报道中，《南华早报》采访了其他人，其中一位国际出版界人士透露了其看法。
机器翻译如下：
据一位在国际学术出版领域深耕多年的中国业内人士透露，花费数十万甚至上百万元人民币来换取发表论文的机会，已成为一种“心照不宣”的现象，在顶级医学期刊中尤为常见。
出于对该问题敏感性的考量，这位不愿具名的业内人士解释称，这种做法旨在提高论文被录用的几率。
例如，直接投稿往往在第一轮审稿时就极易被拒；但若能建立起“内部关系”，期刊编辑或许会给予作者更多机会，甚至提供具体的修改指导。
“我听说有些期刊已经针对此类交易对相关编辑进行了内部惩处，但这些事大多仅在圈内流传，”他补充道，但并未提供任何已证实的具体案例。
谈及为何作者愿意斥巨资“贿赂”期刊，该业内人士指出，这主要是因为在中国，在顶级期刊上发表论文所能获得的激励与回报“实在太高了”。
“这本质上就是一种投资，”他说。他指出，一旦论文在顶级期刊上发表，随之而来的往往是“各种学术头衔、资源以及科研经费”。
原文：
According to a veteran Chinese professional in the international academic publishing sector, spending hundreds of thousands or even millions of yuan to open a possibility of securing publication was a “tacitly understood” phenomenon, particularly in top-tier medical journals.
Speaking on condition of anonymity, citing the sensitivity of the matter, the insider explained that this practice served to increase the probability of publication.
For instance, a direct submission was highly likely to be rejected outright in the first round. However, once an internal relationship was established, journal editors might grant the author more opportunities and provide specific guidance for revisions.
“I have heard of some journals already disciplining certain editors internally over such transactions, but these incidents mostly just circulate within the circle,” he added, without providing details of any confirmed cases of the practice.
As to why authors would be willing to spend massive sums to bribe journals, the industry insider said it was primarily because the incentives and rewards associated with prestigious publications in China “are too high”.
“It is essentially an investment,” he said, noting that once a paper was published in a top journal, “all sorts of academic titles, resources and research grants follow”.”
https://www.scmp.com/news/china/science/article/3371384/cell-publisher-investigates-editor-accused-soliciting-bribes-china
来源：饶议科学
4001102288 欢迎批评指正
All Rights Reserved 新浪公司 版权所有
